Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases

Tomonori Nakanoko, Tadashi Koga, Kenji Taketani, Yoshie Hirayama, Shohei Yoshiya, Ryosuke Minagawa, Masanori Kai, Kiyoshi Kajiyama, Yoshihiko Maehara

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Small bowel adenocarcinoma is an uncommon disease with poor prognosis. Therefore, characteristics and treatment strategies for small bowel adenocarcinoma should be elucidated sufficiently, not only for surgery, but also for chemotherapy. Patients and Methods: Medical records were abstracted to identify patients with small bowel adenocarcinoma who were treated at the Iizuka Hospital, Fukuoka, Japan, between 2004 and 2014. The results of surgical treatment for stage II/III cases and the efficacy of chemotherapy for unresectable stage IV cases were investigated. Results: The median tumor size was 25.6±19.2 mm, and tumor size was not associated with primary symptoms. Nine of the patients were diagnosed with stage II/III disease and underwent surgical resection. The other three patients were diagnosed with stage IV disease, and two out of those three cases received definitive chemotherapy. In two out of the nine resected cases, recurrence was observed; however, surgical resection of the recurrent tumor was associated with a good prognosis. In stage IV cases that received chemotherapy, survival durations of over 11 months were achieved. In contrast, overall survival in the stage IV case without chemotherapy was 3.3 months. Conclusion: Curative resection and definitive chemotherapy for unresectable cases are effective treatment strategies for small bowel adenocarcinoma.

Original languageEnglish
Pages (from-to)4135-4138
Number of pages4
JournalAnticancer research
Volume35
Issue number7
Publication statusPublished - Jul 1 2015

Fingerprint

Adenocarcinoma
Drug Therapy
Therapeutics
Neoplasms
Survival
Medical Records
Japan
Recurrence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Nakanoko, T., Koga, T., Taketani, K., Hirayama, Y., Yoshiya, S., Minagawa, R., ... Maehara, Y. (2015). Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases. Anticancer research, 35(7), 4135-4138.

Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases. / Nakanoko, Tomonori; Koga, Tadashi; Taketani, Kenji; Hirayama, Yoshie; Yoshiya, Shohei; Minagawa, Ryosuke; Kai, Masanori; Kajiyama, Kiyoshi; Maehara, Yoshihiko.

In: Anticancer research, Vol. 35, No. 7, 01.07.2015, p. 4135-4138.

Research output: Contribution to journalArticle

Nakanoko, T, Koga, T, Taketani, K, Hirayama, Y, Yoshiya, S, Minagawa, R, Kai, M, Kajiyama, K & Maehara, Y 2015, 'Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases', Anticancer research, vol. 35, no. 7, pp. 4135-4138.
Nakanoko T, Koga T, Taketani K, Hirayama Y, Yoshiya S, Minagawa R et al. Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases. Anticancer research. 2015 Jul 1;35(7):4135-4138.
Nakanoko, Tomonori ; Koga, Tadashi ; Taketani, Kenji ; Hirayama, Yoshie ; Yoshiya, Shohei ; Minagawa, Ryosuke ; Kai, Masanori ; Kajiyama, Kiyoshi ; Maehara, Yoshihiko. / Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases. In: Anticancer research. 2015 ; Vol. 35, No. 7. pp. 4135-4138.
@article{04af5e4ae8244ba59c42a916eeed5901,
title = "Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases",
abstract = "Background: Small bowel adenocarcinoma is an uncommon disease with poor prognosis. Therefore, characteristics and treatment strategies for small bowel adenocarcinoma should be elucidated sufficiently, not only for surgery, but also for chemotherapy. Patients and Methods: Medical records were abstracted to identify patients with small bowel adenocarcinoma who were treated at the Iizuka Hospital, Fukuoka, Japan, between 2004 and 2014. The results of surgical treatment for stage II/III cases and the efficacy of chemotherapy for unresectable stage IV cases were investigated. Results: The median tumor size was 25.6±19.2 mm, and tumor size was not associated with primary symptoms. Nine of the patients were diagnosed with stage II/III disease and underwent surgical resection. The other three patients were diagnosed with stage IV disease, and two out of those three cases received definitive chemotherapy. In two out of the nine resected cases, recurrence was observed; however, surgical resection of the recurrent tumor was associated with a good prognosis. In stage IV cases that received chemotherapy, survival durations of over 11 months were achieved. In contrast, overall survival in the stage IV case without chemotherapy was 3.3 months. Conclusion: Curative resection and definitive chemotherapy for unresectable cases are effective treatment strategies for small bowel adenocarcinoma.",
author = "Tomonori Nakanoko and Tadashi Koga and Kenji Taketani and Yoshie Hirayama and Shohei Yoshiya and Ryosuke Minagawa and Masanori Kai and Kiyoshi Kajiyama and Yoshihiko Maehara",
year = "2015",
month = "7",
day = "1",
language = "English",
volume = "35",
pages = "4135--4138",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "7",

}

TY - JOUR

T1 - Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases

AU - Nakanoko, Tomonori

AU - Koga, Tadashi

AU - Taketani, Kenji

AU - Hirayama, Yoshie

AU - Yoshiya, Shohei

AU - Minagawa, Ryosuke

AU - Kai, Masanori

AU - Kajiyama, Kiyoshi

AU - Maehara, Yoshihiko

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background: Small bowel adenocarcinoma is an uncommon disease with poor prognosis. Therefore, characteristics and treatment strategies for small bowel adenocarcinoma should be elucidated sufficiently, not only for surgery, but also for chemotherapy. Patients and Methods: Medical records were abstracted to identify patients with small bowel adenocarcinoma who were treated at the Iizuka Hospital, Fukuoka, Japan, between 2004 and 2014. The results of surgical treatment for stage II/III cases and the efficacy of chemotherapy for unresectable stage IV cases were investigated. Results: The median tumor size was 25.6±19.2 mm, and tumor size was not associated with primary symptoms. Nine of the patients were diagnosed with stage II/III disease and underwent surgical resection. The other three patients were diagnosed with stage IV disease, and two out of those three cases received definitive chemotherapy. In two out of the nine resected cases, recurrence was observed; however, surgical resection of the recurrent tumor was associated with a good prognosis. In stage IV cases that received chemotherapy, survival durations of over 11 months were achieved. In contrast, overall survival in the stage IV case without chemotherapy was 3.3 months. Conclusion: Curative resection and definitive chemotherapy for unresectable cases are effective treatment strategies for small bowel adenocarcinoma.

AB - Background: Small bowel adenocarcinoma is an uncommon disease with poor prognosis. Therefore, characteristics and treatment strategies for small bowel adenocarcinoma should be elucidated sufficiently, not only for surgery, but also for chemotherapy. Patients and Methods: Medical records were abstracted to identify patients with small bowel adenocarcinoma who were treated at the Iizuka Hospital, Fukuoka, Japan, between 2004 and 2014. The results of surgical treatment for stage II/III cases and the efficacy of chemotherapy for unresectable stage IV cases were investigated. Results: The median tumor size was 25.6±19.2 mm, and tumor size was not associated with primary symptoms. Nine of the patients were diagnosed with stage II/III disease and underwent surgical resection. The other three patients were diagnosed with stage IV disease, and two out of those three cases received definitive chemotherapy. In two out of the nine resected cases, recurrence was observed; however, surgical resection of the recurrent tumor was associated with a good prognosis. In stage IV cases that received chemotherapy, survival durations of over 11 months were achieved. In contrast, overall survival in the stage IV case without chemotherapy was 3.3 months. Conclusion: Curative resection and definitive chemotherapy for unresectable cases are effective treatment strategies for small bowel adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=84937122559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937122559&partnerID=8YFLogxK

M3 - Article

C2 - 26124367

AN - SCOPUS:84937122559

VL - 35

SP - 4135

EP - 4138

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 7

ER -